FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine and can be used to accelerate the recovery of the number of erythrocytes and hemoglobin in rats after hemorrhage, which is a model of posthemorrhagic anemia. To do this, the animals are administered intramuscular Mo72Fe30 – nanocluster iron-molybdenum polyoxometallate (IMP) of the Keplerian type [Mo72Fe30O252(CH3COO)12{Mo2O7(H2O)}2{H2Mo2O8(H2O)}(H2O)91]⋅150H2O. Administration is carried out in a dose of 0.15 mg/100 g sevenfold 1 time per day.
EFFECT: method ensures the acceleration of natural regeneration of erythrocytes by directional delivery of iron contained in iron-molybdenum polyoxometallates.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR CORRECTION OF VIOLATIONS IN HEMOGENESIS ERYTHROID LINEAGE CAUSED BY CYSTOSTATIC IMPACT | 2016 |
|
RU2634572C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ANAEMIA OF CHRONIC DISEASES AND IRON DEFICIENCY ANAEMIA IN PATIENTS WITH INFLAMMATORY JOINT DISEASES | 2024 |
|
RU2825523C1 |
| METHOD FOR DIAGNOSING ANEMIA OF CHRONIC DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2021 |
|
RU2783248C1 |
| PHARMACOLOGICAL COMPOSITION BASED ON WATER-SOLUBLE POLYMETAL COMPLEXES OF POLYGALACTURONIC ACID, STIMULATING HEMATOPOIESIS PROCESS | 2019 |
|
RU2704033C1 |
| METHOD OF TREATING ANAEMIA IN PREGNANT WOMEN | 2013 |
|
RU2532387C1 |
| METHOD FOR TREATING ANEMIA DURING PREGNANCY | 2006 |
|
RU2319489C2 |
| AGENT FOR STIMULATING PROLIFERATIVE ACTIVITY OF BONE MARROW CELLS | 2023 |
|
RU2811901C1 |
| READY-TO-USE INJECTION COMPOSITION FOR PREVENTING AND TREATING IRON DEFICIENCY ANAEMIA | 2016 |
|
RU2720512C1 |
| METHOD FOR PREDICTION OF ANEMIA IN PREGNANT WOMEN WITH CYTOMEGALOVIRUS INFECTION | 2019 |
|
RU2710588C1 |
| METHOD OF MICROCARDIODYSTROPHY DIAGNOSTICS FOR PATIENTS SUFFERING FROM CHRONIC IRON-DEFICIENCY ANAEMIA | 2006 |
|
RU2328743C1 |
